Solodyn Recall: Bottles May Contain a Different Medication

On Monday, the FDA announced a recall for certain lots of Solodyn Extended Release Tablets since they could contain the wrong medication. Individuals who filled a prescription for the antibiotic Solodyn (minocycline), may have actually received bottles containing Azasan (azathioprine), an immunosuppressant. This could pose a severe safety risk to consumers.

The Solodyn recall applies to 90 mg, 30-count bottles (NDC 99207-461-30) of the extended release tablets from lot numbers B080037 and B080038. Both lots contain an expiration date of December 2009, and were manufactured in February 2008. The medication is sold by Medicis and manufactured under a contract with AAIPharma, Inc.

Solodyn is an antibiotic primarily prescribed to treat acne for those 12 years of age or older. Azasan, is a potent immunosuppressive agent which is prescribed to kidney transplant patients to help prevent their body from rejecting the organ. It is also used for treatment of rheumatoid arthritis, by decreasing the effects of certain cells in the body’s immune system.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The product mix-up could expose individuals who were prescribed Solodyn to a risk of potentially severe adverse effects, especially among the elderly or those who are taking multiple medications. Common side effects of Azasan could include reduction of red and white blood cells and platelets (mylosuppression), infection, bleeding, chills, nausea, vomiting, diarrhea, joint pain and muscle pain. It could also cause severe problems if the drug causes unanticipated interactions with other drugs.

>>RELATED RESOURCES: Solodyn Recall Lawsuits

2 Comments

  • ShamiraNovember 26, 2017 at 2:00 am

    I was prescribed minocycline in 2010 to prevent blistering after a laser treatment. I was hospitalized several times over the next 2 years after that because I lost over 15 pounds in 2 weeks, I lost nerve functioning in my legs, and I was an actress. I found no answers until I just read this. Please help me fight these assholes.

  • Solodyn Lawsuits — AboutLawsuits.comMay 20, 2008 at 3:42 am

    [...] On May 16, 2008 a Solodyn recall was issued for lot numbers B080037 (Exp: 12/09) and B080038 (Exp: 12/09) of the 90mg tablets sold in [...]

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery
Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery (Posted today)

A federal magistrate judge is forcing Uber to hand over potentially hundreds of thousands of incident files involving reports of passengers who suffered sexual misconduct or sexual assault at the hands of the rideshare service's drivers.

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted yesterday)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted 2 days ago)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.